Cargando…

Outcomes and Predictors of Early Mortality After Continuous-Flow Left Ventricular Assist Device Implantation as a Bridge to Transplantation

Left ventricular assist devices (LVADs) are fast becoming standard of care for patients with advanced heart failure. However, despite continuous improvement in VAD technology, there remains a significant early postoperative morbidity and mortality in this extreme patient group. The aim of the curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabashnikov, Anton, Mohite, Prashant N., Zych, Bartlomiej, García, Diana, Popov, Aron-Frederik, Weymann, Alexander, Patil, Nikhil P., Hards, Rachel, Capoccia, Massimo, Wahlers, Thorsten, De Robertis, Fabio, Bahrami, Toufan, Amrani, Mohamed, Banner, Nicholas R., Simon, André R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942348/
https://www.ncbi.nlm.nih.gov/pubmed/24399066
http://dx.doi.org/10.1097/MAT.0000000000000035
_version_ 1782479053351026688
author Sabashnikov, Anton
Mohite, Prashant N.
Zych, Bartlomiej
García, Diana
Popov, Aron-Frederik
Weymann, Alexander
Patil, Nikhil P.
Hards, Rachel
Capoccia, Massimo
Wahlers, Thorsten
De Robertis, Fabio
Bahrami, Toufan
Amrani, Mohamed
Banner, Nicholas R.
Simon, André R.
author_facet Sabashnikov, Anton
Mohite, Prashant N.
Zych, Bartlomiej
García, Diana
Popov, Aron-Frederik
Weymann, Alexander
Patil, Nikhil P.
Hards, Rachel
Capoccia, Massimo
Wahlers, Thorsten
De Robertis, Fabio
Bahrami, Toufan
Amrani, Mohamed
Banner, Nicholas R.
Simon, André R.
author_sort Sabashnikov, Anton
collection PubMed
description Left ventricular assist devices (LVADs) are fast becoming standard of care for patients with advanced heart failure. However, despite continuous improvement in VAD technology, there remains a significant early postoperative morbidity and mortality in this extreme patient group. The aim of the current study was to explore the short-term outcomes and predictors for 90 day mortality in the patients after implantation of continuous-flow LVAD. Perioperative clinical, echocardiographic, hemodynamic, and laboratory data of 90 day survivors and nonsurvivors were collected and compared retrospectively. Multivariate logistic regression analysis was performed on univariate predictors for 90 day mortality with an entry criterion of p < 0.1. Between July 2006 and May 2012, 117 patients underwent implantation of a continuous-flow LVAD as a bridge to transplantation: 71 (60.7%) HeartMate II (Thoratec Corp, Pleasanton, CA) and 46 (39.3%) HVAD (HeartWare International, Framingham, MA). All-cause 90 day mortality was 17.1%. Multivariate analysis revealed higher preoperative central venous pressure (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.014–1.378; p = 0.033) and higher age (OR, 1.14; 95% CI, 1.01–1.38; p = 0.045) as the only independent predictors for 90 day mortality. Optimization of preoperative volume status, preload, and right heart function as well as age-based selection of candidates for LVAD support are the critical factors influencing early outcome after continuous-flow LVAD implantation.
format Online
Article
Text
id pubmed-3942348
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-39423482014-03-05 Outcomes and Predictors of Early Mortality After Continuous-Flow Left Ventricular Assist Device Implantation as a Bridge to Transplantation Sabashnikov, Anton Mohite, Prashant N. Zych, Bartlomiej García, Diana Popov, Aron-Frederik Weymann, Alexander Patil, Nikhil P. Hards, Rachel Capoccia, Massimo Wahlers, Thorsten De Robertis, Fabio Bahrami, Toufan Amrani, Mohamed Banner, Nicholas R. Simon, André R. ASAIO J Adult Circulatory Support Left ventricular assist devices (LVADs) are fast becoming standard of care for patients with advanced heart failure. However, despite continuous improvement in VAD technology, there remains a significant early postoperative morbidity and mortality in this extreme patient group. The aim of the current study was to explore the short-term outcomes and predictors for 90 day mortality in the patients after implantation of continuous-flow LVAD. Perioperative clinical, echocardiographic, hemodynamic, and laboratory data of 90 day survivors and nonsurvivors were collected and compared retrospectively. Multivariate logistic regression analysis was performed on univariate predictors for 90 day mortality with an entry criterion of p < 0.1. Between July 2006 and May 2012, 117 patients underwent implantation of a continuous-flow LVAD as a bridge to transplantation: 71 (60.7%) HeartMate II (Thoratec Corp, Pleasanton, CA) and 46 (39.3%) HVAD (HeartWare International, Framingham, MA). All-cause 90 day mortality was 17.1%. Multivariate analysis revealed higher preoperative central venous pressure (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.014–1.378; p = 0.033) and higher age (OR, 1.14; 95% CI, 1.01–1.38; p = 0.045) as the only independent predictors for 90 day mortality. Optimization of preoperative volume status, preload, and right heart function as well as age-based selection of candidates for LVAD support are the critical factors influencing early outcome after continuous-flow LVAD implantation. Lippincott Williams & Wilkins 2014-03 2014-02-28 /pmc/articles/PMC3942348/ /pubmed/24399066 http://dx.doi.org/10.1097/MAT.0000000000000035 Text en Copyright © 2014 by the American Society for Artificial Internal Organs http://creativecommons.org/licenses/by-nc-nd/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivitives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Adult Circulatory Support
Sabashnikov, Anton
Mohite, Prashant N.
Zych, Bartlomiej
García, Diana
Popov, Aron-Frederik
Weymann, Alexander
Patil, Nikhil P.
Hards, Rachel
Capoccia, Massimo
Wahlers, Thorsten
De Robertis, Fabio
Bahrami, Toufan
Amrani, Mohamed
Banner, Nicholas R.
Simon, André R.
Outcomes and Predictors of Early Mortality After Continuous-Flow Left Ventricular Assist Device Implantation as a Bridge to Transplantation
title Outcomes and Predictors of Early Mortality After Continuous-Flow Left Ventricular Assist Device Implantation as a Bridge to Transplantation
title_full Outcomes and Predictors of Early Mortality After Continuous-Flow Left Ventricular Assist Device Implantation as a Bridge to Transplantation
title_fullStr Outcomes and Predictors of Early Mortality After Continuous-Flow Left Ventricular Assist Device Implantation as a Bridge to Transplantation
title_full_unstemmed Outcomes and Predictors of Early Mortality After Continuous-Flow Left Ventricular Assist Device Implantation as a Bridge to Transplantation
title_short Outcomes and Predictors of Early Mortality After Continuous-Flow Left Ventricular Assist Device Implantation as a Bridge to Transplantation
title_sort outcomes and predictors of early mortality after continuous-flow left ventricular assist device implantation as a bridge to transplantation
topic Adult Circulatory Support
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942348/
https://www.ncbi.nlm.nih.gov/pubmed/24399066
http://dx.doi.org/10.1097/MAT.0000000000000035
work_keys_str_mv AT sabashnikovanton outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT mohiteprashantn outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT zychbartlomiej outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT garciadiana outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT popovaronfrederik outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT weymannalexander outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT patilnikhilp outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT hardsrachel outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT capocciamassimo outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT wahlersthorsten outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT derobertisfabio outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT bahramitoufan outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT amranimohamed outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT bannernicholasr outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation
AT simonandrer outcomesandpredictorsofearlymortalityaftercontinuousflowleftventricularassistdeviceimplantationasabridgetotransplantation